Corporate Banner
Satellite Banner
Technology Networks Header
Monday, October 20, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Optibrium Introduces the Latest Release of StarDrop™
Wednesday, October 15, 2014
StarDrop 6.0 gives researchers the freedom to explore and organise complex project data in a flexible and intuitive way.

Improving the Consistency & Efficiency of Early Drug Discovery
Wednesday, October 15, 2014
Consistency and efficiency of assays improved by using VIAFLO II pipettes and a VIAFLO ASSIST from INTEGRA.

PerkinElmer Launches New AlphaLISA® SureFire® Ultra Assays
Thursday, October 09, 2014
Offering reduces assay time by up to 50 percent and enhances detection process for life science researchers.

Avacta Extends Optim® 2 Product Family for Even Greater Measurement Flexibility
Thursday, October 09, 2014
An innovative analytical instrument designed to probe multiple protein stability.

FUJIFILM Diosynth Biotechnologies Announces the Launch of ‘Apollo™’
Thursday, October 09, 2014
New mammalian expression platform designed to create a robust ‘manufacturing-ready’ cell line.

Phenomenex Introduces First Synthetic Sorbent for SLE
Wednesday, October 08, 2014
Novum Simplified Liquid Extraction - Ideal for the cleanup of biological samples.

New SLE and SPE Automation System from Biotage - Flexible, Simple and Reliable
Saturday, October 04, 2014
New Biotage® Extrahera™ for the processing of SLE and SPE methods in both plate and column formats.

High Throughput COMET Assay System
Saturday, October 04, 2014
COMPAC-50 - Designed specifically for rapid high throughput single cell gel electrophoresis.

Versatile Code Reading Software for Sample Storage
Saturday, October 04, 2014
New software is easy to install, gives reliable code readings and can be smoothly integrated into any laboratory sample database.

<< 1 2 3 4 5 6 7 >>
Showing Results 1 - 10 of 2587
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv